Surgical treatment for esophageal cancer during the outbreak of COVID-19
10.3760/cma.j.cn112152-20200226-00128
- VernacularTitle: 新型冠状病毒肺炎疫情下食管癌患者外科诊治对策
- Author:
Yong LI
1
;
Jianjun QIN
1
;
Zhen WANG
1
;
Yuan YU
1
;
Yongyao WEN
2
;
Xiankai CHEN
1
;
Weixin LIU
2
;
Yin LI
1
Author Information
1. Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
2. Department of Thoracic Surgery, Cancer Hospital of Huanxing, ChaoYang District, Beijing 100022, China
- Publication Type:Journal Article
- Keywords:
COVID-19;
Esophageal neoplasms;
Surgery;
Diagnosis and treatment strategy
- From:
Chinese Journal of Oncology
2020;42(0):E003-E003
- CountryChina
- Language:Chinese
-
Abstract:
Since December 2019, unexplained pneumonia has appeared in Wuhan City, Hubei Province, and a new type of coronavirus infection was confirmed as COVID-19. COVID-19 spread rapidly nationwide and abroad. The COVID-19 has brought huge impacts to all the people and walks of life, especially to the medical and health systems. It has also brought great challenges to the treatment of patients with cancer. Esophageal cancer is a common malignant tumor in China and most of the patients are in the middle and advanced stage when diagnosed, with immunosuppressive and poor prognosis. The selection of surgical procedures and perioperative managements of esophageal cancer require all thoracic surgeons work together to figure out a reasonable system of surgical treatment and emergency response.
